Prion protein genes and prion diseases: studies in transgenic mice

被引:24
|
作者
Telling, GC
机构
[1] Univ Kentucky, Dept Microbiol & Immunol, Sanders Brown Ctr Aging, Lexington, KY 40536 USA
[2] Univ Kentucky, Dept Neurol, Lexington, KY 40536 USA
关键词
prions; transgenic mice;
D O I
10.1046/j.1365-2990.2000.00253.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
In the past decade, manipulation of PrP genes by transgenesis in mice has provided important insights into mechanisms of prion propagation and the molecular basis of prion strains and species barriers. Despite these advances, our understanding of these unique pathogens is far from complete. This review focuses on PrP gene knockout and gene replacement studies, PrP structure and function, and transgenic models of human and animal prion diseases. Transgenic approaches will doubtless remain the cornerstone of investigations into the prion diseases in the coming years, which will include mechanistic studies of prion pathogenesis and prion transmission barriers. Transgenic models will also be important tools for the evaluation of potential therapeutic agents for prion diseases.
引用
收藏
页码:209 / 220
页数:12
相关论文
共 50 条
  • [31] Cellular prion protein neuroprotective function: implications in prion diseases
    Roucou, X
    LeBlanc, AC
    JOURNAL OF MOLECULAR MEDICINE-JMM, 2005, 83 (01): : 3 - 11
  • [32] Distribution of intraneuronal immunoreactivity for the prion protein in human prion diseases
    Kovacs, GG
    Voigtländer, T
    Hainfellner, JA
    Budka, H
    ACTA NEUROPATHOLOGICA, 2002, 104 (03) : 320 - 326
  • [33] Cerebrospinal Fluid Total Prion Protein in the Spectrum of Prion Diseases
    Anna Villar-Piqué
    Matthias Schmitz
    Ingolf Lachmann
    André Karch
    Olga Calero
    Christiane Stehmann
    Shannon Sarros
    Anna Ladogana
    Anna Poleggi
    Isabel Santana
    Isidre Ferrer
    Eva Mitrova
    Dana Žáková
    Maurizio Pocchiari
    Inês Baldeiras
    Miguel Calero
    Steven J. Collins
    Michael D. Geschwind
    Raquel Sánchez-Valle
    Inga Zerr
    Franc Llorens
    Molecular Neurobiology, 2019, 56 : 2811 - 2821
  • [34] Prion protein aggregation assays in the diagnosis of human prion diseases
    Green, Alison J. E.
    FUTURE NEUROLOGY, 2015, 10 (03) : 217 - 228
  • [35] Potential approaches for heterologous prion protein treatment of prion diseases
    Seelig, Davis M.
    Goodman, Patricia A.
    Skinner, Pamela J.
    PRION, 2016, 10 (01) : 18 - 24
  • [36] Peripheral circulation of the prion infectious agent in transgenic mice expressing the ovine prion protein gene in neurons only
    Crozet, Carole
    Lezmi, Stephane
    Flamant, Frederic
    Samarut, Jacques
    Baron, Thierry
    Bencsik, Anna
    JOURNAL OF INFECTIOUS DISEASES, 2007, 195 (07): : 997 - 1006
  • [37] Distribution of intraneuronal immunoreactivity for the prion protein in human prion diseases
    Gabor G. Kovacs
    Till Voigtländer
    Johannes A. Hainfellner
    Herbert Budka
    Acta Neuropathologica, 2002, 104 : 320 - 326
  • [38] Cellular prion protein neuroprotective function: implications in prion diseases
    Xavier Roucou
    Andréa C. LeBlanc
    Journal of Molecular Medicine, 2005, 83 : 3 - 11
  • [39] Unusual cerebral vascular prion protein amyloid distribution in scrapie-infected transgenic mice expressing anchorless prion protein
    Alejandra Rangel
    Brent Race
    Mikael Klingeborn
    James Striebel
    Bruce Chesebro
    Acta Neuropathologica Communications, 1
  • [40] CHIMERIC PRION PROTEIN EXPRESSION IN CULTURED-CELLS AND TRANSGENIC MICE
    SCOTT, MR
    KOHLER, R
    FOSTER, D
    PRUSINER, SB
    PROTEIN SCIENCE, 1992, 1 (08) : 986 - 997